Danone S.A.
GPDNF
Other OTC76.52
USD
+3.42
- -
CIK
0001048515
ISIN
FR0000120644
Return %
Stock
S&P500
1Y
-10.47
26.57
3Y
28.82
76.60
5Y
9.58
78.48
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Antoine Bernard de Saint-Affrique
- Full Time Employees
- 89,528
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Address
- 17, Boulevard Haussmann Paris France 75009
- IPO Date
- Jul 18, 2001
- CIK
- 0001048515
- Website
- danone.com
- Similar Companies
- Business
- Danone S.A. (Ticker: GPDNF) is a leading global food and beverage company that specializes in health-focused products across three core categories: essential dairy and plant-based products including yogurts, fermented milks, fresh cheeses, plant-based alternatives under brands such as Activia, Actimel, Alpro, Oikos, Silk and Danio; waters encompassing plain bottled waters, flavored waters and reduced-sugar beverages via brands like Evian, Volvic, Bonafont and Aquadrinks; and specialized nutrition comprising early life nutrition for infants and medical nutrition for patients with specific health needs through brands including Aptamil, Nutrilon, Nutricia and Real Food Blends. Founded in 1919 in Barcelona, Spain, and headquartered at 17 Boulevard Haussmann in Paris, France, the company operates in over 120 countries with approximately 90,000 employees worldwide, targeting consumers, families, healthcare professionals and patients seeking everyday nutrition, hydration, immunity support, gut health and life-stage-specific solutions. Danone maintains its Société à Mission status under its Renew Danone strategic plan, emphasizing sustainable growth, healthier product categories (89% of sales) and positive societal impact through pillars of health, nature and communities. In recent developments, Danone completed the acquisition of a majority stake in U.S.-based Kate Farms in 2025, enhancing its specialized nutrition portfolio with plant-based, organic medical and everyday nutrition products and integrating them alongside Nutricia and Functional Formularies to expand access in North America; launched a $65 million expansion of its Jacksonville, Florida facility in 2025 to boost coffee creamer production for brands like International Delight, Silk and SToK while adding a regional distribution center and 200 jobs; invested €20 million in its Punjab, India nutrition facility to scale early life and medical nutrition output under brands like Protinex as part of geographic expansion; and progressed its Renew Danone strategy with H1 2025 sales growth of 4.2% like-for-like, driven by volume/mix and pricing amid focus on core categories.